Erlotinib u nemocných s nemalobuněčným karcinomem plic (NSCLC) : sledování účinnosti u nemocných v České republice

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	Erlotinib in patients with non-small cell lung cancer (NSCLC): Followup of efficacy in patients in the Czech Republic
Authors	SALAJKA František SKŘIČKOVÁ Jana PEŠEK M. ZATLOUKAL P.
Year of publication	2010
Type	Article in Proceedings
Conference	Sborník XXXIV. Brněnské onkologické dny
MU Faculty or unit	Faculty of Medicine
Citation
Field	Pneumology
Keywords	Erlotinib; NSCLS; Czech Republic
Description	Efficacy of Erlotinib in treatment of non-small cell lung cancer (NSCLC) was followed up in this Czech multi-centre study.
Related projects:	Environment - carcinogenesis - oncology